Literature DB >> 28718381

Histological and Immunohistochemical Characterization of the Similarity and Difference Between Ovarian Endometriomas and Deep Infiltrating Endometriosis.

Xishi Liu1,2, Qi Zhang1, Sun-Wei Guo1,2.   

Abstract

Ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) have long been recognized to have different histology and, as such, postulated to be 2 separate disease entities. Few studies, however, have attempted to elucidate the causes for their differences. Making use of ectopic endometrial tissue samples from 25 and 20 women with OMA and DIE, respectively, and control endometrial tissue samples from 25 women without endometriosis, we conducted an immunohistochemical analysis to evaluate the expression of a group of carefully chosen markers for epithelial-mesenchymal transition (EMT), fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), fibrosis, vascularity, hormonal receptors, and proteins involved in epigenetic modifications. We found that both OMA and DIE lesions exhibited the same cellular changes consistent with EMT, FMT, SMM, and fibrosis as already shown in animal models. Compared to OMA, DIE lesions underwent more thorough and extensive EMT, FMT, and SMM and, consequently, displayed significantly higher fibrotic content but less vascularity. The 2 conditions also showed different expression levels of hormonal receptors. Both OMA and DIE lesions, especially the latter, showed significantly higher staining of enhancer of zeste homolog 2, H3K9me3, and H3K27me3 than that of control endometrium, suggesting progressive epigenetic changes concomitant with cellular ones. Finally, proteins that are known to be involved in fibrogenesis, such as thymocyte differentiation antigen 1 and peroxisome proliferator-activated receptor γ , were also aberrantly expressed under both conditions. The many similarities shared by both OMA and DIE indicate that the 2 conditions may actually share the same pathogenesis/pathophysiology. Their differences, however, suggest that the source of these differences may result from the different lesional microenvironments.

Entities:  

Keywords:  deep infiltrating endometriosis; epigenetics; epithelial–mesenchymal transition; fibroblast-to-myofibroblast transdifferentation; fibrosis; histology; immunohistochemistry; ovarian endometriomas; smooth muscle metaplasia

Mesh:

Substances:

Year:  2017        PMID: 28718381     DOI: 10.1177/1933719117718275

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  22 in total

1.  Effects of histone methyltransferase inhibition in endometriosis.

Authors:  Mariano Colón-Caraballo; Annelyn Torres-Reverón; John Lee Soto-Vargas; Steven L Young; Bruce Lessey; Adalberto Mendoza; Raúl Urrutia; Idhaliz Flores
Journal:  Biol Reprod       Date:  2018-08-01       Impact factor: 4.285

2.  AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis.

Authors:  Mike R Wilson; Jake J Reske; Ronald L Chandler
Journal:  Reprod Sci       Date:  2022-05-26       Impact factor: 2.924

3.  Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis.

Authors:  Meihua Hao; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2022-06-04       Impact factor: 4.982

4.  Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Sci Rep       Date:  2020-06-11       Impact factor: 4.379

5.  Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis.

Authors:  Yunlei Cao; Xishi Liu; Sun-Wei Guo
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

6.  Establishment of an Immortalized Endometriotic Stromal Cell Line from Human Ovarian Endometrioma.

Authors:  Yong Song; Niraj R Joshi; Erin Vegter; Samantha Hrbek; Bruce A Lessey; Asgerally T Fazleabas
Journal:  Reprod Sci       Date:  2020-06-15       Impact factor: 3.060

7.  Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology.

Authors:  Weilin Zheng; Jie Wang; Jiayi Wu; Tao Wang; Yangxue Huang; Xuefang Liang; Lixing Cao
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

8.  Inhibition of Histone Methyltransferase EZH2 Suppresses Endometriotic Vesicle Development in a Rat Model of Endometriosis.

Authors:  Inevy Seguinot-Tarafa; Nuria Luna; Edu Suarez; Caroline B Appleyard; Idhaliz Flores
Journal:  Reprod Sci       Date:  2020-07-10       Impact factor: 2.924

9.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.